ARA-290 (Cibinetide) holds FDA Orphan Drug Designation for sarcoidosis-associated neuropathic pain but has not received marketing authorisation or clinical approval from the MHRA, FDA, EMA, or any regulatory authority for routine therapeutic use
Bioactive compounds have a wealth of pharmacological activities, including anti-inflammatory [230], antioxidant [49], anti-cancer [5], and protection of intestinal immune homeostasis[287]
4% AHK-Cu (Copper Tripeptide-3): Specifically prized in hair research for its ability to target the hair follicles and support the growth phase (Anagen)
Trabi M, Schirra HJ, Craik DJ: Three-dimensional structure of RTD-1, a cyclic antimicrobial defensin from Rhesus macaque leukocytes
All major credit and debit cards through our secure checkout